← Evidence map

ArticleMedical hypotheses2020

Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease.

Daniel P CashmanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2020
2021
2022
2023
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32758873